ORM-5029
Product Specifications
Target
Antibody-Drug Conjugates (ADCs)
Related Pathways
Antibody-drug Conjugate/ADC Related
Bioactivity
ORM-5029 is the first antibody-drug conjugate (ADC) targeting the human epidermal growth factor receptor 2 (HER2), combining the highly potent GSPT1 degrader SMol006 with Pertuzumab. It is applicable in cancer research.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E-AD-C009-01 20 Tests
Porcine Reproductive and Respiratory Syndrome Virus Antibodies Lateral Flow Assay Kit
Sign In for Pricing
View Details E-AD-C009-02 40 Tests
Porcine Reproductive and Respiratory Syndrome Virus Antibodies Lateral Flow Assay Kit
Sign In for Pricing
View Details 